Incyte (INCY) Selling, General & Administrative (2010 - 2026)
Powered by 
Analysis
Incyte (INCY) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 247.47 Mn |
| 10 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn | 351.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 351.74 Mn |
| Mar 31, 2026 | 328.09 Mn |
| Dec 31, 2025 | 390.41 Mn |
| Sep 30, 2025 | 329.08 Mn |
| Jun 30, 2025 | 331.02 Mn |
| Mar 31, 2025 | 325.69 Mn |
| Dec 31, 2024 | 326.71 Mn |
| Sep 30, 2024 | 309.21 Mn |
| Jun 30, 2024 | 305.98 Mn |
| Mar 31, 2024 | 300.26 Mn |
| Dec 31, 2023 | 288.23 Mn |
| Sep 30, 2023 | 267.89 Mn |
| Jun 30, 2023 | 283.93 Mn |
| Mar 31, 2023 | 315.61 Mn |
| Dec 31, 2022 | 272.82 Mn |
| Sep 30, 2022 | 266.46 Mn |
| Jun 30, 2022 | 253.28 Mn |
| Mar 31, 2022 | 209.58 Mn |
| Dec 31, 2021 | 226.20 Mn |
| Sep 30, 2021 | 190.70 Mn |